We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-2.27%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.23B
AUM Growth
-$236M
Cap. Flow
-$124M
Cap. Flow %
-3.82%
Top 10 Hldgs %
42.87%
Holding
405
New
25
Increased
177
Reduced
155
Closed
37

Sector Composition

Rank Sector Weight
1 Technology 14.38%
2 Healthcare 6.83%
3 Financials 4.82%
4 Industrials 3.49%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IHF icon
276
iShares US Healthcare Providers ETF
IHF
$1.26B
$350K 0.01%
6,631
-1,624
-20% -$83.5K
IWY icon
277
iShares Russell Top 200 Growth ETF
IWY
$16.1B
$349K 0.01%
1,656
+1
+0.1% +$230
NAK
278
Northern Dynasty Minerals
NAK
$818M
$344K 0.01%
298,950
VRTX icon
279
Vertex Pharmaceuticals
VRTX
$119B
$342K 0.01%
706
+57
+9% +$26.6K
COR icon
280
Cencora
COR
$60B
$342K 0.01%
1,228
+2
+0.2% +$502
IGSB icon
281
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$339K 0.01%
6,482
-849
-12% -$44.1K
GEHC icon
282
GE HealthCare
GEHC
$31.5B
$335K 0.01%
4,145
+45
+1% +$3.87K
CLM icon
283
Cornerstone Strategic Value Fund
CLM
$2.2B
$334K 0.01%
45,604
+2,121
+5% +$17.4K
BIV icon
284
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$331K 0.01%
4,324
+23
+0.5% +$1.74K
CTAS icon
285
Cintas
CTAS
$81.6B
$324K 0.01%
1,579
-525
-25% -$105K
IJS icon
286
iShares S&P Small-Cap 600 Value ETF
IJS
$8.28B
$316K 0.01%
3,244
+9
+0.3% +$950
KRE icon
287
State Street SPDR S&P Regional Banking ETF
KRE
$4.69B
$311K 0.01%
5,471
+6
+0.1% +$365
CRWD icon
288
CrowdStrike
CRWD
$206B
$307K 0.01%
3,488
+340
+11% +$32.4K
CEG icon
289
Constellation Energy
CEG
$97.7B
$305K 0.01%
1,514
+62
+4% +$16.6K
IR icon
290
Ingersoll Rand
IR
$34.1B
$305K 0.01%
3,807
-18
-0.5% -$1.57K
BDX icon
291
Becton Dickinson
BDX
$46.9B
$304K 0.01%
1,328
+40
+3% +$9.28K
ECBK icon
292
ECB Bancorp
ECBK
$180M
$303K 0.01%
20,000
PJP icon
293
Invesco Pharmaceuticals ETF
PJP
$467M
$302K 0.01%
3,492
-796
-19% -$67.8K
MUB icon
294
iShares National Muni Bond ETF
MUB
$45.2B
$299K 0.01%
2,836
-10,436
-79% -$1.11M
SKIN icon
295
SkinHealth Systems
SKIN
$90.6M
$294K 0.01%
219,761
VCSH icon
296
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
$294K 0.01%
3,725
+22
+0.6% +$1.73K
ALB icon
297
Albemarle
ALB
$14B
$290K 0.01%
4,029
-85,640
-96% -$6.97M
CNI icon
298
Canadian National Railway
CNI
$76.1B
$290K 0.01%
2,971
+11
+0.4% +$1.11K
ON icon
299
ON Semiconductor
ON
$31.3B
$288K 0.01%
+7,088
New +$357K
SPGI icon
300
S&P Global
SPGI
$123B
$285K 0.01%
561
+26
+5% +$13.3K

Similar funds

Grimes & Company's Q1 2025 Portfolio in Review

As of Q1 2025, Grimes & Company held 405 positions worth $3.23B, down 6.8% from $3.47B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Grimes & Company withdrew a net $124M in Q1 2025, closing 37 positions and reducing 155 holdings. Its most notable exit was State Street Materials Select Sector SPDR ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grimes & Company opened a new position in State Street Financial Select Sector SPDR ETF worth $18.6M.

  • Grimes & Company's largest Q1 2025 buy was State Street Financial Select Sector SPDR ETF: 372,475 shares worth $18.6M.
  • Grimes & Company added most to iShares Core MSCI EAFE ETF in Q1 2025, an estimated $110M increase.
  • Grimes & Company's biggest Q1 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $87.4M.
  • Grimes & Company fully exited State Street Materials Select Sector SPDR ETF in Q1 2025, selling an estimated $13.9M.
  • Grimes & Company's ten largest holdings make up 43% of its $3.23B portfolio in Q1 2025.
  • Grimes & Company opened 25 new positions and closed 37 in Q1 2025.
  • Grimes & Company's portfolio value fell 6.8% quarter-over-quarter to $3.23B.

Based on Grimes & Company's 13F filing for Q1 2025, filed 17 Apr 2025.